Christopher T. Ducko, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgical Procedures | 1 | 2017 | 347 | 0.430 |
Why?
|
| Community Health Services | 1 | 2017 | 654 | 0.400 |
Why?
|
| Respiratory Paralysis | 1 | 2010 | 32 | 0.360 |
Why?
|
| Robotics | 8 | 2001 | 880 | 0.330 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 161 | 0.330 |
Why?
|
| Quadriplegia | 1 | 2010 | 226 | 0.320 |
Why?
|
| Coronary Artery Bypass | 8 | 2001 | 2273 | 0.300 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2753 | 0.270 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 833 | 0.260 |
Why?
|
| Pneumonectomy | 3 | 2021 | 1110 | 0.240 |
Why?
|
| Electric Stimulation Therapy | 1 | 2010 | 613 | 0.240 |
Why?
|
| Pinacidil | 2 | 2000 | 10 | 0.230 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5248 | 0.230 |
Why?
|
| Cardioplegic Solutions | 2 | 2000 | 122 | 0.220 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2015 | 277 | 0.210 |
Why?
|
| Endoscopy | 6 | 2001 | 1841 | 0.190 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13249 | 0.170 |
Why?
|
| Video-Assisted Surgery | 1 | 2000 | 51 | 0.170 |
Why?
|
| Thoracoscopes | 1 | 1999 | 3 | 0.170 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 2623 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15680 | 0.160 |
Why?
|
| Hospitals, Community | 1 | 2021 | 367 | 0.160 |
Why?
|
| Potassium Channels | 2 | 2000 | 532 | 0.150 |
Why?
|
| Hemolysis | 1 | 1994 | 423 | 0.100 |
Why?
|
| Survival Rate | 3 | 2021 | 12806 | 0.090 |
Why?
|
| Diaphragm | 1 | 2010 | 351 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6472 | 0.080 |
Why?
|
| Pericardiectomy | 1 | 2008 | 46 | 0.070 |
Why?
|
| Calcium Chloride | 3 | 2000 | 78 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11141 | 0.070 |
Why?
|
| Potassium Chloride | 3 | 2000 | 233 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 247 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2009 | 768 | 0.060 |
Why?
|
| Equipment Design | 3 | 2000 | 3520 | 0.060 |
Why?
|
| Bicarbonates | 3 | 2000 | 304 | 0.060 |
Why?
|
| Cattle | 4 | 1999 | 3847 | 0.060 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 815 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 609 | 0.060 |
Why?
|
| Sodium Chloride | 3 | 2000 | 596 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1173 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 1994 | 1290 | 0.050 |
Why?
|
| Pericardium | 1 | 2008 | 675 | 0.050 |
Why?
|
| Cisplatin | 1 | 2009 | 1642 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2009 | 806 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 923 | 0.050 |
Why?
|
| Magnesium | 3 | 2000 | 810 | 0.050 |
Why?
|
| Anastomosis, Surgical | 3 | 2000 | 983 | 0.050 |
Why?
|
| Heart Arrest, Induced | 2 | 2000 | 357 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3215 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2021 | 64947 | 0.040 |
Why?
|
| Parabiosis | 1 | 2000 | 64 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 1591 | 0.040 |
Why?
|
| Coronary Circulation | 3 | 2000 | 1578 | 0.040 |
Why?
|
| Rabbits | 3 | 2000 | 4773 | 0.040 |
Why?
|
| Organ Preservation Solutions | 1 | 2000 | 100 | 0.040 |
Why?
|
| Microsurgery | 3 | 2000 | 791 | 0.040 |
Why?
|
| Cell Size | 1 | 2000 | 623 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2155 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3726 | 0.040 |
Why?
|
| Vascular Patency | 4 | 2001 | 901 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2010 | 3737 | 0.030 |
Why?
|
| Male | 12 | 2021 | 359413 | 0.030 |
Why?
|
| Motor Skills | 1 | 2000 | 520 | 0.030 |
Why?
|
| Organ Preservation | 1 | 2000 | 379 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2000 | 780 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 1999 | 385 | 0.030 |
Why?
|
| Female | 12 | 2021 | 391011 | 0.030 |
Why?
|
| Middle Aged | 7 | 2021 | 220175 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 13629 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 1999 | 841 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 168995 | 0.030 |
Why?
|
| Models, Structural | 1 | 1994 | 341 | 0.030 |
Why?
|
| Humans | 12 | 2021 | 760261 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80301 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 1023 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 1999 | 1402 | 0.030 |
Why?
|
| Swine | 2 | 1999 | 5902 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2931 | 0.020 |
Why?
|
| General Surgery | 1 | 2000 | 1681 | 0.020 |
Why?
|
| Feasibility Studies | 4 | 2000 | 5201 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 292 | 0.020 |
Why?
|
| Endoscopes | 2 | 1999 | 168 | 0.020 |
Why?
|
| Myocardium | 1 | 2000 | 4688 | 0.020 |
Why?
|
| Animals | 8 | 2000 | 167940 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3217 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 58673 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 8058 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2009 | 1435 | 0.010 |
Why?
|
| Time Factors | 3 | 2015 | 40133 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2001 | 39 | 0.010 |
Why?
|
| Prognosis | 2 | 2015 | 29636 | 0.010 |
Why?
|
| Adult | 3 | 2010 | 219847 | 0.010 |
Why?
|
| Tromethamine | 1 | 2000 | 31 | 0.010 |
Why?
|
| Surgical Equipment | 1 | 2000 | 57 | 0.010 |
Why?
|
| Raffinose | 1 | 2000 | 53 | 0.010 |
Why?
|
| Thoracic Arteries | 1 | 2000 | 40 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 22066 | 0.010 |
Why?
|
| Allopurinol | 1 | 2000 | 200 | 0.010 |
Why?
|
| Mammary Arteries | 1 | 1998 | 81 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 2544 | 0.010 |
Why?
|
| Glutathione | 1 | 2000 | 582 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 267 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8551 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 1999 | 4560 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2000 | 8553 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1628 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 10185 | 0.010 |
Why?
|
| Adenosine | 1 | 2000 | 833 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 58947 | 0.010 |
Why?
|
| Coronary Disease | 2 | 2000 | 5993 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7072 | 0.010 |
Why?
|
| Operating Rooms | 1 | 2000 | 790 | 0.010 |
Why?
|
| Suture Techniques | 1 | 1998 | 788 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 1096 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20484 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9497 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16905 | 0.010 |
Why?
|
| United States | 2 | 2015 | 72363 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9274 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22041 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 39254 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74269 | 0.000 |
Why?
|
| Glucose | 1 | 2000 | 4361 | 0.000 |
Why?
|
| Acute Disease | 1 | 1998 | 7268 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 3870 | 0.000 |
Why?
|
| Echocardiography | 1 | 1999 | 4980 | 0.000 |
Why?
|
| Insulin | 1 | 2000 | 6592 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18134 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 54263 | 0.000 |
Why?
|